DR. LOUIS IORIO, M.D.

HAMDEN, CT

Research Active
Orthopaedic Surgery NPI registered 21+ years 50 publications 2013 – 2026 NPI: 1043216575
Case-Control StudiesGlucocorticoidsImmunosuppressive AgentsSurveys and QuestionnairesSeverity of Illness IndexRecurrenceItalyParkinson DiseaseMalnutritionAntibodies, Monoclonal, HumanizedConstipationAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisGranulomatosis with PolyangiitisLevodopaPolymyalgia Rheumatica

Practice Location

9 WASHINGTON AVE
HAMDEN, CT 06518-3267

Phone: (203) 865-6784

What does LOUIS IORIO research?

Dr. Iorio studies a range of autoimmune diseases, notably eosinophilic myocarditis, granulomatosis with polyangiitis, and eosinophilic granulomatosis with polyangiitis. His research often involves novel treatments, like monoclonal antibodies, which are engineered proteins that help the immune system address these complex conditions. He looks at how these treatments can not only improve health—like enhancing heart function or reducing inflammation—but also how they can minimize reliance on traditional medications that may have significant side effects. Additionally, he investigates the immune system's behavior in patients, even during remission, and evaluates innovative approaches to prevent or manage these diseases.

Key findings

  • In eosinophilic myocarditis treatment, heart function improved from an average of 47% to 55% in patients receiving monoclonal antibodies, with harmful eosinophil levels dropping from 95% to 11%.
  • In granulomatosis with polyangiitis, systemic immunosuppressive therapy significantly reduced relapse rates from 82% for systemic therapy to 18% for local treatments.
  • The long-term use of benralizumab in eosinophilic granulomatosis with polyangiitis led to remission rates rising from 39% to 65% over three years and a decrease in corticosteroid use from 90% to 15%.
  • In a study of patients with VEXAS syndrome, it was found that 75% experienced cartilage inflammation and 80% suffered from severe infections, highlighting the syndrome's significant impact on health.
  • Switching to subcutaneous infliximab in Takayasu arteritis was successful, with 77.8% of patients continuing treatment after one year and 87.5% remaining in remission.

Frequently asked questions

Does Dr. Iorio study eosinophilic myocarditis?
Yes, Dr. Iorio researches eosinophilic myocarditis and explores effective treatment options for this condition.
What treatments has Dr. Iorio researched?
Dr. Iorio has investigated monoclonal antibodies, glucocorticoids, and newer biologic therapies for various autoimmune diseases.
Is Dr. Iorio's work relevant to patients with granulomatosis with polyangiitis?
Absolutely, his research focuses on treatment strategies and outcomes specifically for patients with granulomatosis with polyangiitis.
Can Dr. Iorio's research help patients in remission?
Yes, his studies on immune system behavior in patients in remission highlight the importance of ongoing monitoring to prevent relapses.
What is VEXAS syndrome, and does Dr. Iorio study it?
VEXAS syndrome is a rare inflammatory disorder, and Dr. Iorio studies it to enhance diagnosis and understanding of its impacts on patients.

Publications in plain English

Outcomes of an Intravenous to Subcutaneous Infliximab (CT-P13) Strategy in Takayasu Arteritis: A Proof-of-Concept Prospective Study.

2026

ACR open rheumatology

Iorio L, Davanzo F, Fiorin E, Codirenzi M, Prevedello R +2 more

Plain English
This study looked at how well patients with Takayasu arteritis could switch from receiving infliximab through an IV to making the switch to a subcutaneous (under the skin) version. The researchers found that 77.8% of patients continued the subcutaneous treatment after a year, and 87.5% remained in remission, indicating that the new method worked effectively without causing serious problems. This is important because it shows that switching to a more convenient treatment method can still keep patients stable and healthy. Who this helps: Patients with Takayasu arteritis seeking effective treatment options.

PubMed

Immature leukocyte and plasma-induced cell death reveal subclinical immune activation in EGPA patients in remission.

2026

Inflammation research : official journal of the European Histamine Research Society ... [et al.]

Baggio C, Iorio L, Boscaro C, Davanzo F, Davanzo V +8 more

Plain English
This study focused on understanding the immune system's behavior in patients with eosinophilic granulomatosis with polyangiitis (EGPA) who are in remission from a type of autoimmune disease called ANCA-associated vasculitis (AAV). Researchers found that these patients had more immature neutrophils, which are a type of white blood cell, and their blood plasma caused significant cell death and increased inflammation in immune cells from healthy donors. These results indicate that even when patients appear to be in remission, there is ongoing low-level immune activation, which may increase the risk of disease relapse. Who this helps: This study benefits patients with AAV, especially those who are in remission, by highlighting the importance of monitoring their immune status.

PubMed

Clinical outcomes of subglottic stenosis in granulomatosis with polyangiitis: results of an international multicentre observational study.

2026

Rheumatology (Oxford, England)

Gallina GD, Lanzillotta M, Maggioni S, Cariddi A, Danè G +27 more

Plain English
This study examined how subglottic stenosis (narrowing of the airway) affects patients with granulomatosis with polyangiitis, focusing on treatment effectiveness and patterns of relapse. Among 89 patients, more than half (54%) experienced multiple relapses, with systemic immunosuppressive therapy significantly reducing relapse rates (82% compared to just 18% for local treatments). Key findings showed that using cyclophosphamide led to longer periods without relapses, while relying solely on glucocorticoids was linked to higher relapse rates. Who this helps: This research benefits patients suffering from subglottic stenosis due to granulomatosis with polyangiitis and their doctors by providing clearer treatment guidelines.

PubMed

Evolving Therapeutic Strategies in ANCA-Associated Vasculitis: Current Standards and Emerging Targets for GPA and MPA.

2026

Clinical reviews in allergy & immunology

Dal Pozzolo R, Iorio L, Davanzo F, Zanatta E, Iaccarino L +5 more

Plain English
This study focused on improving treatments for two serious autoimmune diseases, Granulomatosis with polyangiitis (GPA) and Microscopic polyangiitis (MPA). Researchers found that while standard treatments like glucocorticoids and rituximab are effective, there's a push towards using less glucocorticoids to lower side effects and developing new targeted therapies that can provide better results. This shift aims for safer, more tailored treatments that can help patients achieve lasting health without the heavy burden of side effects. Who this helps: Patients with GPA and MPA.

PubMed

Monoclonal antibodies targeting IL-5/5R or IL-4/13 pathways in eosinophilic myocarditis: a single-center experience and systematic literature review.

2026

European heart journal. Cardiovascular pharmacotherapy

Giordani AS, Menghi C, Baritussio A, Scognamiglio F, Vicenzetto C +8 more

Plain English
This study looked at patients with eosinophilic myocarditis (a rare heart condition) treated with specific antibodies (mepolizumab, benralizumab, and dupilumab) alongside other treatments. Among 37 patients, those receiving these antibodies experienced significant health improvements: their heart function increased from an average of 47% to 55%, and harmful eosinophil levels dropped from 95% to 11%. Importantly, none of these patients had relapses or required heart transplants, demonstrating that these treatments can control the disease effectively and safely. Who this helps: This information benefits patients with eosinophilic myocarditis and their doctors.

PubMed

Epstein-Barr virus-positive lymphoproliferative disorder mimicking eosinophilic granulomatosis with polyangiitis.

2025

Rheumatology (Oxford, England)

Iorio L, Pizzi M, Davanzo F, Dei Tos AP, Doria A +1 more

PubMed

Dupilumab for refractory chronic rhinosinusitis in eosinophilic granulomatosis with polyangiitis.

2025

Rheumatology (Oxford, England)

Padoan R, Davanzo F, Iorio L, Saccardo T, Roccuzzo G +4 more

Plain English
This study looked at how well a drug called dupilumab works for patients with eosinophilic granulomatosis with polyangiitis (EGPA) who have ongoing severe nasal issues that don't respond to other treatments. Among the nine patients studied, 55.6% had no symptoms after three months, and this improved to 83.3% after twelve months. Additionally, patients reported better quality of life and significant reductions in markers of inflammation, although some faced side effects. Who this helps: Patients suffering from severe nasal issues related to EGPA.

PubMed

Advances in the treatment of polymyalgia rheumatica.

2025

Rheumatology (Oxford, England)

Iorio L, Bond M, Padoan R, Dejaco C

Plain English
This study focused on improving the treatment of polymyalgia rheumatica (PMR), a common inflammation condition in people over 50. It found that while the usual treatment with glucocorticoids (steroids) helps, up to 76% of patients experience relapses, and 85% suffer from side effects of long-term use. Newer options, like biologic drugs and JAK inhibitors, could reduce reliance on steroids and help patients reach remission, emphasizing the importance of specialized care and better treatment strategies. Who this helps: This helps patients with polymyalgia rheumatica.

PubMed

Recycling Waste Fiberglass by Powder Grinding and Direct Molding of Powders.

2025

Polymers

Quadrini F, Iorio L, Patrizii G, Bellisario D, Santo L

Plain English
This research explored how to recycle waste fiberglass by turning it into a powder and molding it directly into new products without extra materials. The study found that the recycled fiberglass had a density of 1.23 g/cm, a bending strength of 28 MPa, and a consistent quality with only 7% variation. This method is important because it shows that valuable materials can be created from waste fiberglass, reducing the need for new resources. Who this helps: This benefits manufacturers looking for sustainable materials and reduces waste in the fiberglass industry.

PubMed

Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: data from a European multicentre study.

2025

Rheumatology (Oxford, England)

Delvino P, Quartuccio L, Robson JC, Ferretti VV, Klersy C +34 more

Plain English
This study examined how the drug mepolizumab affects quality of life for patients with eosinophilic granulomatosis with polyangiitis (EGPA). Researchers found that patients experienced significant health improvements within days of starting the treatment, with scores on the AAV-PRO questionnaire showing a marked decrease—particularly in areas like physical function and overall wellbeing—over a six-month period. These results are important because they demonstrate that mepolizumab not only controls the disease but also dramatically enhances patients' quality of life. Who this helps: This benefits patients with eosinophilic granulomatosis with polyangiitis.

PubMed

Primordial and primary prevention in rheumatological diseases: The time has come.

2025

Autoimmunity reviews

Scagnellato L, Salvato M, Iorio L, Moccaldi B, Giollo A +4 more

Plain English
This study looks at the prevention of rheumatological diseases, which are conditions that affect the immune system and often lead to long-term disability, especially in women of working age. It found that there is a rise in these diseases despite advancements in treatments, and early interventions targeting things like smoking, obesity, and diet can help delay or prevent disease onset. The authors emphasize the need for more research on prevention strategies, particularly for those at higher risk, such as family members of patients with these diseases. Who this helps: This helps patients at risk of rheumatological diseases and their families.

PubMed

Long-term effectiveness and safety of benralizumab in EGPA: a 3-year single-center experience.

2025

Annals of medicine

Davanzo F, Iorio L, Codirenzi M, Fiorin E, Guarnieri G +6 more

Plain English
This study looked at the long-term effects and safety of a medication called benralizumab for patients with a serious condition known as eosinophilic granulomatosis with polyangiitis (EGPA), particularly those who also have severe asthma. Over three years, the number of patients in remission increased from about 39% to 65%, and their need for corticosteroids dropped significantly from 90% to 15%. This is important because it shows that benralizumab can effectively help manage symptoms and reduce reliance on steroids. Who this helps: This benefits patients with EGPA and their doctors by providing a more effective treatment option.

PubMed

Colorectal perforation following anorectal manometry in a patient with anal stenosis post rectal prolapse repair: a rare complication.

2025

Journal of surgical case reports

Iorio L, Matos MC, Linkous B, Ferrara M, Caycedo A

Plain English
This study looked into a rare but serious complication that can happen during a diagnostic test called anorectal manometry (ARM), specifically focusing on a 77-year-old woman who had previous surgeries for rectal prolapse. After the test, she experienced rectal bleeding and imaging showed a significant tear in her rectum, but she remained stable and fully recovered with non-invasive treatment, including rest and antibiotics. This highlights the need to carefully consider the risks of such procedures in patients with a history of rectal issues and shows that conservative treatment can be effective for these types of injuries. Who this helps: This benefits patients undergoing anorectal procedures, their doctors, and particularly those with prior rectal surgeries.

PubMed

VEXAS syndrome in rheumatology practice: features from a multicenter cohort in north-east Italy.

2025

Frontiers in immunology

Bindoli S, Morello-Pasin G, Guidea I, Padoan R, Iorio L +11 more

Plain English
This study looked at VEXAS syndrome, a rare inflammatory disorder found in older adults, especially men. Researchers analyzed data from 37 patients over 50 years old and found that all patients showed symptoms like fatigue and joint pain, with 75% experiencing chondritis (inflammation of cartilage) and 80% facing severe infections. The findings highlight that VEXAS syndrome may be more common than previously thought, and better awareness among doctors is crucial for early diagnosis and treatment. Who this helps: This helps patients with VEXAS syndrome and the doctors treating them.

PubMed

Subclinical giant cell arteritis in polymyalgia rheumatica: Concurrent conditions or a common spectrum of inflammatory diseases?

2024

Autoimmunity reviews

Salvarani C, Padoan R, Iorio L, Tomelleri A, Terrier B +2 more

Plain English
This study looked at the relationship between giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) in older adults. It found that 23 to 29% of new PMR patients also have subclinical GCA, meaning they show signs of GCA without clear symptoms. Understanding this connection is important because early detection of GCA can prevent serious health issues, particularly since GCA can lead to higher mortality, especially in patients with aortic problems. Who this helps: This benefits patients, especially those recently diagnosed with PMR.

PubMed

Might maintenance therapy be discontinued once clinical remission is achieved in ANCA-associated vasculitis?

2024

Autoimmunity reviews

Roccatello D, Padoan R, Sciascia S, Iorio L, Nic An Ríogh E +1 more

Plain English
This study looked at whether patients with ANCA-associated vasculitis (AAV) can stop their ongoing treatment once they achieve clinical remission. The researchers found two main options for maintaining treatment: using specific biomarkers to guide personalized therapy or tailoring treatment based on the type of antibodies present in the patient’s blood. This matters because it could lead to safer and more effective ways to manage the condition while reducing the risks associated with long-term medication use. Who this helps: This helps patients with ANCA-associated vasculitis.

PubMed

Combination of monoclonal antibodies targeting type 2 inflammation for severe asthma and eosinophilic granulomatosis with polyangiitis.

2024

Autoimmunity reviews

Davanzo F, Marchi MR, Iorio L, Bortoli M, Doria A +1 more

Plain English
Researchers studied the use of two monoclonal antibodies together to treat severe asthma and a related condition in a 54-year-old woman who had not improved with previous treatments. They found that combining the drugs dupilumab and benralizumab helped reduce her asthma symptoms and lower her blood eosinophil levels, without any side effects over a year. This research shows that using combination therapies can be both safe and effective for patients who struggle with poorly controlled type 2 inflammation-related diseases. Who this helps: Patients with severe asthma and eosinophilic granulomatosis who haven’t responded to other treatments.

PubMed

Cutting-Edge Strategies for Renal Tumour-like Lesions in Granulomatosis with Polyangiitis: A Systematic Review.

2024

Diagnostics (Basel, Switzerland)

Iorio L, Pizzi M, Cecchin D, Davanzo F, Ghirardello A +3 more

Plain English
This study looked at a condition called Granulomatosis with Polyangiitis (GPA), which can cause kidney problems that appear like tumors. Researchers found that out of 42 patients with these kidney issues, 86.5% tested positive for a specific antibody related to GPA, and treatment with steroids and other medications led to a high success rate in managing the disease. Recognizing GPA as a potential cause for kidney lesions is important for proper diagnosis and treatment, as effective management can lead to better health outcomes for patients. Who this helps: This helps patients with kidney issues and doctors who treat them.

PubMed

Aberrant Diagnostic Imaging Resulting in Misdiagnosed Acute Perforated Appendicitis: A Case Report.

2024

Cureus

Przeslawski C, Iorio L, Gerken J

Plain English
This case report studied a 31-year-old man who was initially diagnosed with perforated diverticulitis based on a CT scan but, during surgery, was found to actually have acute perforated appendicitis. The correct diagnosis was only made after he underwent a procedure called diagnostic laparoscopy. This matters because it emphasizes how important thorough medical evaluations are, even when imaging tests suggest one diagnosis, and how laparoscopy can reduce the risks associated with more invasive surgeries. Who this helps: This helps patients who may have similar abdominal issues, ensuring they receive the right treatment.

PubMed

Investigational agents for polymyalgia rheumatica treatment: assessing the critical needs for future development.

2024

Expert opinion on investigational drugs

Iorio L, Padoan R, Bond M, Dejaco C

Plain English
This research looked at polymyalgia rheumatica (PMR), a condition that causes pain and stiffness in the shoulders and hips and often responds to steroid treatments. Researchers found that while steroids are commonly used, there are many trials (12 ongoing) testing new medicines that might reduce the need for steroids, including options like IL-6 receptor inhibitors and other new drugs. This is important because it could lead to better treatment options and fewer side effects for patients with PMR. Who this helps: Patients with polymyalgia rheumatica.

PubMed

Cocaine- and Levamisole-Induced Vasculitis: Defining the Spectrum of Autoimmune Manifestations.

2024

Journal of clinical medicine

Iorio L, Davanzo F, Cazzador D, Codirenzi M, Fiorin E +4 more

Plain English
This study looked at how using cocaine and a chemical called levamisole can lead to serious immune system problems known as vasculitis. Researchers found that these substances can cause a range of issues, from mild nasal problems to severe systemic diseases, and noted that around 80% of patients with drug-induced vasculitis showed overlapping symptoms with other types of autoimmune diseases. Understanding these effects is important because it helps doctors diagnose and treat patients more effectively, especially when drug use is not immediately recognized. Who this helps: This helps doctors and patients struggling with drug-related health issues.

PubMed

Compression Molding of Low-Density Polyethylene Matrix/Glass-Fiber-Reinforced Thick Laminates.

2024

Polymers

Quadrini F, Patrizii G, Proietti A, Iorio L, Bellisario D +1 more

Plain English
This study looked at making thick panels from recycled materials like fiberglass and thermoplastic films, using a simplified method that speeds up the process. The researchers found that these new panels can be repaired multiple times, which improves their usability, although their strength is lower than traditional fiberglass, with a maximum strength of under 10 MPa. This is important because it shows that we can create durable materials from waste that can be repaired, helping to reduce waste and promote recycling. Who this helps: This benefits manufacturers and industries looking for sustainable materials.

PubMed

Expanding the VEXAS diagnostic workup: the role of peripheral blood cytological analysis.

2024

Frontiers in immunology

Baggio C, Oliviero F, Padoan R, Iorio L, Bixio R +10 more

Plain English
This study looked at VEXAS syndrome, a newly recognized condition caused by mutations in a specific gene, by analyzing blood samples from VEXAS patients compared to those with other inflammatory diseases and healthy individuals. The researchers found that VEXAS patients had more vacuoles and immature neutrophils in their blood cells, along with higher rates of cell death, which could help in diagnosing this condition. This is important because it provides a way to identify VEXAS syndrome amid various similar disorders, enhancing accurate diagnosis and management. Who this helps: This helps doctors and healthcare providers diagnose patients with VEXAS syndrome more effectively.

PubMed

Localized topological states beyond Fano resonances via counter-propagating wave mode conversion in piezoelectric microelectromechanical devices.

2024

Nature communications

De Ponti JM, Zhao X, Iorio L, Maggioli T, Colangelo M +4 more

Plain English
This research studied a new type of small device designed to more accurately sense very tiny changes, like the mass of a single cell, which traditional devices struggle with. The scientists created a microelectromechanical system (MEMS) using special materials that can work effectively by leveraging unique wave patterns, resulting in improved performance for localized measurements. This is important because it could lead to advancements in various fields, including medical diagnostics and communications technologies. Who this helps: Patients and doctors who need precise measurements for better health monitoring and diagnosis.

PubMed

Validation of the 2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis.

2023

Rheumatology (Oxford, England)

Tomelleri A, Padoan R, Kavadichanda CG, Jose A, Singh K +8 more

Plain English
This study looked at new criteria for diagnosing Takayasu arteritis (TAK) to see how well they performed compared to older criteria. Researchers analyzed data from 504 TAK patients and 222 control subjects, finding that the new 2022 criteria were more sensitive (95.8% vs. 82.9%) but less specific (63.5% vs. 90.5%) than the older criteria. This is important because better sensitivity means more true cases of TAK would be caught, but lower specificity could lead to misdiagnoses. Who this helps: This helps doctors diagnose TAK more accurately, particularly in female patients.

PubMed

Reinforcement learning optimisation for graded metamaterial design using a physical-based constraint on the state representation and action space.

2023

Scientific reports

Rosafalco L, De Ponti JM, Iorio L, Craster RV, Ardito R +1 more

Plain English
This study focused on improving the energy-harvesting ability of special materials called graded metamaterials, which are designed with tiny resonators that can capture energy from vibrations. Researchers discovered that using a method called reinforcement learning (RL) made these materials more efficient at harvesting energy under random conditions. In comparison to traditional optimization methods, RL showed better results when energy was collected from unpredictable vibrations, outperforming other techniques especially when random frequencies were involved. Who this helps: This benefits engineers and researchers developing energy-harvesting technologies.

PubMed

Clinical correlates of serum 25-hydroxyvitamin D in Parkinson's disease.

2022

Nutritional neuroscience

Barichella M, Cereda E, Iorio L, Pinelli G, Ferri V +16 more

Plain English
This study looked at vitamin D levels in 500 patients with Parkinson's disease and compared them to 100 healthy individuals. It found that 65.6% of the Parkinson's patients had low vitamin D levels, which were linked to more severe disease symptoms and worse cognitive functions. This matters because it suggests that vitamin D deficiency may worsen Parkinson’s disease, highlighting the need for further research to explore potential treatments. Who this helps: This helps patients with Parkinson's disease and their doctors.

PubMed

Biologic therapy in relapsing polychondritis: navigating between options.

2022

Expert opinion on biological therapy

Padoan R, Campaniello D, Iorio L, Doria A, Schiavon F

Plain English
This study looked at treatments for relapsing polychondritis (RP), a rare disease that causes inflammation in body tissues, particularly cartilage. It found that biologic therapies, like TNF inhibitors, abatacept, and tocilizumab, can help patients, especially when conventional treatments fail. For example, TNF inhibitors showed a positive effect in many patients, but their effectiveness may decrease over time. Who this helps: This benefits patients with relapsing polychondritis who need effective treatment options.

PubMed

How the First Year of the COVID-19 Pandemic Impacted Patients' Hospital Admission and Care in the Vascular Surgery Divisions of the Southern Regions of the Italian Peninsula.

2022

Journal of personalized medicine

Martelli E, Sotgiu G, Saderi L, Federici M, Sangiorgi G +55 more

Plain English
This study looked at how the COVID-19 pandemic affected the number of patients needing vascular surgery in southern Italy during the first year of lockdowns. Researchers found that hospital admissions for routine care dropped significantly: from 9,161 patients in 2019 to 7,092 in 2020. However, there was an increase in emergency surgeries, with admissions for urgent revascularization rising due to more patients suffering from severe vascular issues. Who this helps: This research benefits doctors and healthcare planners by highlighting changes in patient care needs during the pandemic.

PubMed

Bib Sign in Proximal Descending Thoracic Aorta Rupture on CT Angiography: Presentation of a Paradigmatic Case.

2022

Case reports in radiology

Pierro A, Posa A, Iorio L, Tanzilli A, Cucciolillo L +4 more

Plain English
This study looked at how certain signs on CT scans can help doctors recognize early ruptures in the aorta, which is a major blood vessel in the chest. Researchers discovered a new indicator, referred to as the "Bib Sign," that could help identify these dangerous conditions more quickly. Timely diagnosis is crucial because it allows for faster treatment, which can save lives. Who this helps: This benefits patients with potential aortic ruptures and the doctors treating them.

PubMed

Shape Memory Composite Sandwich Structures with Self-Healing Properties.

2021

Polymers

Quadrini F, Bellisario D, Iorio L, Santo L, Pappas P +3 more

Plain English
This research looked at developing a new type of sandwich structure made from materials that can change shape and heal themselves when damaged. The team found that by using low amounts of healing capsules, the structure could recover its shape by 99% and could repair itself to 98% of its original strength after being damaged. This is important because it means these materials could be used in various industries to create longer-lasting and safer products. Who this helps: This benefits manufacturers and engineers in industries that require durable materials.

PubMed

Nutritional characterisation of Zambian: acceptability and safety of short-term daily supplementation in a group of malnourished girls.

2019

International journal of food sciences and nutrition

Barichella M, Pezzoli G, Faierman SA, Raspini B, Rimoldi M +13 more

Plain English
The study looked at how adding a local plant called MO, which is rich in protein, minerals, and vitamins, can help combat malnutrition in girls in Zambia. Researchers found that taking a daily dose of 14 grams of MO powder over 30 days was safe and well-received by the children. This is important because it offers a practical way to improve nutrition using available local resources. Who this helps: This benefits malnourished children and their families.

PubMed

Joint replacement in X-linked hypophosphatemia.

2019

Journal of orthopaedics

Mills ES, Iorio L, Feinn RS, Duignan KM, Macica CM

Plain English
This study looked at how well joint replacements work for patients with X-linked hypophosphatemia (XLH), a condition that causes severe joint problems. Researchers analyzed data from 11 patients who had 14 knee replacements and 7 hip replacements, finding that their physical function scores improved, with knee scores averaging 31.4 and hip scores averaging 14.8 several years after surgery. These results show that joint replacements can significantly help improve mobility and quality of life for people with XLH. Who this helps: Patients with X-linked hypophosphatemia and their healthcare providers.

PubMed

Muscle-targeted nutritional support for rehabilitation in patients with parkinsonian syndrome.

2019

Neurology

Barichella M, Cereda E, Pinelli G, Iorio L, Caroli D +12 more

Plain English
This study looked at how a special nutritional supplement, designed to support muscle health, impacts the recovery of patients with Parkinson's disease or similar conditions during intensive rehabilitation. Researchers found that patients who took this supplement walked an average of 69.6 meters farther in a 6-minute walking test than those who did not take the supplement, with notable improvements in walking speed and balance as well. This matters because it shows that better nutrition can lead to significant physical gains for patients undergoing rehabilitation. Who this helps: This helps patients with Parkinson's disease and their healthcare providers.

PubMed

FESEM evaluation of smear layer removal using different irrigant activation methods (EndoActivator, EndoVac, PUI and LAI). An in vitro study.

2018

Clinical oral investigations

Mancini M, Cerroni L, Iorio L, Dall'Asta L, Cianconi L

Plain English
This study looked at different methods for cleaning out the smear layer from the inside of tooth root canals, which is important for effective dental treatment. Researchers tested four methods: EndoActivator, EndoVac, Passive Ultrasonic Irrigation (PUI), and Laser Activated Irrigation (LAI) on 80 extracted teeth. They found that EndoActivator was the best at cleaning the smear layer at 3, 5, and 8 millimeters from the tooth tip, while EndoVac was more effective at 1 millimeter from the tip; neither method completely cleaned the canals, but they did significantly outperform other methods. Who this helps: This research benefits dentists who want to improve the effectiveness of root canal treatments.

PubMed

Dietary habits and neurological features of Parkinson's disease patients: Implications for practice.

2017

Clinical nutrition (Edinburgh, Scotland)

Barichella M, Cereda E, Cassani E, Pinelli G, Iorio L +14 more

Plain English
This study looked at how the diets of people with Parkinson's disease are connected to their symptoms and treatment. Researchers examined 600 Parkinson's patients and 600 healthy individuals and found that patients had lower body weight and higher food intake. Specifically, increasing protein intake improved their treatment response, with an extra 10 grams of protein leading to a rise in medication needs by 0.7 mg/kg/day, which highlights the importance of nutrition in managing Parkinson's disease symptoms. Who this helps: This helps Parkinson's patients and their healthcare providers.

PubMed

Protein-redistribution diet in a case of tyrosine hydroxylase enzyme deficiency.

2017

Movement disorders : official journal of the Movement Disorder Society

Cassani E, Barichella M, Ferri V, Pusani C, Goldwurm S +8 more

PubMed

Dietary habits in Parkinson's disease: Adherence to Mediterranean diet.

2017

Parkinsonism & related disorders

Cassani E, Barichella M, Ferri V, Pinelli G, Iorio L +12 more

Plain English
This study looked at the eating habits of 600 Italian patients with Parkinson's Disease and compared them to a similar group of 600 people without the condition. The findings showed that while Parkinson's patients scored similarly on a Mediterranean diet adherence scale (4.8 vs. 4.9), they consumed less alcohol, fish, and liquids like water and milk, but ate more fruits, cooked vegetables, and sweets. Understanding these dietary patterns is important because it can lead to better nutrition management for Parkinson's patients, especially since those with swallowing issues drank less fluids. Who this helps: This helps patients with Parkinson's Disease and their caregivers.

PubMed

Determining the Feasibility of Managing Erectile Dysfunction in Humans With Placental-Derived Stem Cells.

2016

The Journal of the American Osteopathic Association

Levy JA, Marchand M, Iorio L, Cassini W, Zahalsky MP

Plain English
This study looked at the use of stem cells from the placenta to treat erectile dysfunction (ED) in men whose condition was often linked to issues like diabetes or high blood pressure. After receiving the stem cell injections, some patients showed improvements in blood flow to the penis, with peak flow speeds increasing from an initial average of about 26 cm/s to nearly 74 cm/s by the six-month follow-up. Two patients who had not responded to other treatments were able to have erections on their own after the treatment. Who this helps: This helps men with erectile dysfunction, especially those who haven't had success with traditional treatments.

PubMed

Diuretic plants in the Bible: ethnobotanical aspects.

2016

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia

Aliotta G, De Santo NG, Iorio L

Plain English
Researchers studied plants mentioned in the Bible that are known to help with urine production, known as diuretics. They reviewed past efforts to identify these plants and found no consensus on their scientific names, highlighting that different experts often disagree. This matters because understanding these plants can shed light on ancient medical practices and potentially benefit modern herbal medicine. Who this helps: Patients seeking natural diuretic remedies.

PubMed

Sarcopenia and Dynapenia in Patients With Parkinsonism.

2016

Journal of the American Medical Directors Association

Barichella M, Pinelli G, Iorio L, Cassani E, Valentino A +7 more

Plain English
This study looked at older patients with Parkinson's disease and other parkinsonian syndromes to see how common two specific conditions, sarcopenia (low muscle mass) and dynapenia (low muscle strength), were among them. Out of 364 patients, only 6.6% had sarcopenia, but a significant 75.5% had dynapenia, particularly affecting their ability to carry out daily activities. These findings highlight how these conditions can worsen the challenges faced by people with Parkinson's, emphasizing the importance of physical therapy in maintaining strength and mobility. Who this helps: This helps patients with Parkinson's disease and their caregivers.

PubMed

Probiotics and prebiotic fiber for constipation associated with Parkinson disease: An RCT.

2016

Neurology

Barichella M, Pacchetti C, Bolliri C, Cassani E, Iorio L +8 more

Plain English
This study looked at how well a fermented milk drink with probiotics and prebiotic fiber helps people with Parkinson's disease who struggle with constipation. The researchers found that, after four weeks, patients drinking the probiotic drink had an average increase of 1.2 complete bowel movements per week compared to just 0.1 in those who had a placebo. This is important because it shows that this drink can significantly improve bowel health for people with Parkinson's, making daily life easier for them. Who this helps: Patients with Parkinson's disease suffering from constipation.

PubMed

Increased urinary indoxyl sulfate (indican): new insights into gut dysbiosis in Parkinson's disease.

2015

Parkinsonism & related disorders

Cassani E, Barichella M, Cancello R, Cavanna F, Iorio L +6 more

Plain English
This study looked at a substance called indican in the urine of people with Parkinson’s disease (PD) to better understand changes in their gut bacteria. It found that indicate levels were significantly higher in PD patients (68 participants) and those who were newly diagnosed (34 participants) compared to healthy individuals (50 participants), with the differences being very noticeable (P values indicating strong significance). These findings are important because they highlight gut imbalances as a key issue in Parkinson’s disease, which could help inform new treatment strategies. Who this helps: This helps patients with Parkinson’s disease and their doctors by providing insights into potential gut-related health challenges.

PubMed

Endothelial progenitor cells: Cardiovascular protection in Parkinson's disease?

2015

International journal of cardiology

Pezzoli G, Cavanna F, Cassani E, Barichella M, Pinelli G +7 more

PubMed

Effects of Stem Cell Treatment in Human Patients With Peyronie Disease.

2015

The Journal of the American Osteopathic Association

Levy JA, Marchand M, Iorio L, Zribi G, Zahalsky MP

Plain English
In this study, researchers explored the use of stem cells from placental tissue to treat Peyronie disease, which causes painful curvature of the penis and erectile dysfunction. They treated five patients with these stem cells and found that, after three months, seven out of ten fibrous plaques had completely disappeared, and there were significant improvements in blood flow to the penis. This matters because it offers a potential nonsurgical treatment option for men suffering from this condition. Who this helps: This helps patients with Peyronie disease looking for effective non-surgical treatment options.

PubMed

[Foam in urine: from Hippocrates to the Medical School of Salerno].

2014

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia

Iorio L, Lamagna M

Plain English
This study examines how the understanding of foam in urine has evolved from ancient times to the Medical School of Salerno. It found that while early scholars recognized foam as a sign of potential illness, interpretations varied: Galen thought it was caused by air in the urine, while later thinkers linked it to serious bodily imbalances, particularly relating to digestion and liver function. Understanding these historical perspectives helps modern medicine better interpret symptoms related to kidney and liver health. Who this helps: Patients experiencing urinary symptoms and doctors diagnosing kidney or liver issues.

PubMed

Accuracy of an electronic apex locator in the retreatment of teeth obturated with plastic or cross-linked gutta-percha carrier-based materials: an ex vivo study.

2014

Journal of endodontics

Mancini M, Palopoli P, Iorio L, Conte G, Cianconi L

Plain English
This study looked at how well a special electronic device called the Root ZX apex locator can measure the length of canals in teeth that have been previously treated and filled with two types of materials. The researchers found that the device tended to measure longer than the actual canal length, which might lead dentists to mistakenly remove too much material during retreatment. Specifically, the electronic measurements were consistently higher than the actual length, which means there’s a risk of putting too much filling in the tooth. Who this helps: This helps dentists and endodontic specialists who treat patients with previously filled teeth.

PubMed

Nutritional risk and gastrointestinal dysautonomia symptoms in Parkinson's disease outpatients hospitalised on a scheduled basis.

2013

The British journal of nutrition

Barichella M, Cereda E, Madio C, Iorio L, Pusani C +4 more

Plain English
This study looked at how certain swallowing and digestive problems in Parkinson's disease (PD) patients might impact their risk of malnutrition. Researchers found that 17.2% of the 208 patients they studied were at risk of malnutrition, mainly due to unintentional weight loss. Patients with more digestive issues had a higher risk of malnutrition, and it was also linked to the severity of their disease and the amount of medication they were taking. Who this helps: This research benefits Parkinson's patients and their healthcare providers.

PubMed

Nutritional status and dietary habits in Parkinson's disease patients in Ghana.

2013

Nutrition (Burbank, Los Angeles County, Calif.)

Barichella M, Akpalu A, Cham M, Privitera G, Cassani E +5 more

Plain English
Researchers studied the eating habits and nutritional health of 55 patients with Parkinson's disease in Ghana compared to 12 healthy individuals. They found that both groups had a daily caloric intake of about 1200 calories, mainly from semisolid foods like vegetable soups and starches, but only a small amount of dairy. Almost half of the Parkinson's patients experienced constipation, and 21% had difficulties swallowing, which highlights significant dietary challenges that need addressing for better management of the disease. Who this helps: This helps patients with Parkinson's disease and their healthcare providers.

PubMed

Smear layer removal and canal cleanliness using different irrigation systems (EndoActivator, EndoVac, and passive ultrasonic irrigation): field emission scanning electron microscopic evaluation in an in vitro study.

2013

Journal of endodontics

Mancini M, Cerroni L, Iorio L, Armellin E, Conte G +1 more

Plain English
This study looked at how well different cleaning methods can remove a sticky layer from the insides of tooth canals during root canal treatments. Researchers tested three techniques on 65 extracted human teeth and found that the EndoVac method was the most effective, cleaning the layers at all measured distances from the tip of the tooth. The EndoActivator also worked well but was not as effective as EndoVac, especially at greater distances from the tip. Who this helps: This research benefits dentists looking to improve the effectiveness of root canal treatments.

PubMed

Frequent Co-Authors

Roberto Padoan Andrea Doria Michela Barichella Emanuele Cereda Erica Cassani Gianni Pezzoli Federica Davanzo Giovanna Pinelli Chiara Pusani Carlotta Bolliri

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.